RESEARCH AND DEVELOPMENT EXPENSES

12 Months Ended

Dec. 31, 2019

Research And Development Expenses

NOTE 22 - RESEARCH AND DEVELOPMENT EXPENSES

Research and development expenses, excluding stock-based compensation and depreciation expenses, allocated to our major research and development programs are as follows:

In Thousands of US Dollars
	For the Year Ended December 31,
Research and Development Program	2019		2018		2017
Research and Development Program	$	4	$	2	$	1
Alzheimer’s Disease: Therapeutics		4		-		2
Anti-Infectives		4		4		4
BPH (Enlarged Prostate) and Prostate Cancer Therapeutics		5,932		4,917		5,268
Tobacco Exposure Tests: NicAlert™ and TobacAlert™		18		2		9
Total	$	5,962	$	4,925	$	5,284